NO20044096L - Inhalsjonsett inneholdende inhalerbart pulver av tiotropium - Google Patents

Inhalsjonsett inneholdende inhalerbart pulver av tiotropium

Info

Publication number
NO20044096L
NO20044096L NO20044096A NO20044096A NO20044096L NO 20044096 L NO20044096 L NO 20044096L NO 20044096 A NO20044096 A NO 20044096A NO 20044096 A NO20044096 A NO 20044096A NO 20044096 L NO20044096 L NO 20044096L
Authority
NO
Norway
Prior art keywords
tiotropium
kit containing
inhalable powder
containing inhalable
inhalation kit
Prior art date
Application number
NO20044096A
Other languages
English (en)
Inventor
Bernd Zierenberg
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28685844&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20044096(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20044096L publication Critical patent/NO20044096L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A61M15/0026—Hinged caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0041—Details of the piercing or cutting means with movable piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20044096A 2002-04-09 2004-09-27 Inhalsjonsett inneholdende inhalerbart pulver av tiotropium NO20044096L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02007868 2002-04-09
PCT/EP2003/003431 WO2003084502A1 (en) 2002-04-09 2003-04-02 Inhalation kit comprisung inhalable powder of tiotropium

Publications (1)

Publication Number Publication Date
NO20044096L true NO20044096L (no) 2004-10-20

Family

ID=28685844

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044096A NO20044096L (no) 2002-04-09 2004-09-27 Inhalsjonsett inneholdende inhalerbart pulver av tiotropium

Country Status (30)

Country Link
EP (1) EP1496858B1 (no)
JP (1) JP2005525393A (no)
KR (1) KR101017850B1 (no)
CN (2) CN100522135C (no)
AR (1) AR039276A1 (no)
AU (1) AU2009200716B2 (no)
BR (1) BR0309117A (no)
CA (1) CA2481876C (no)
CY (1) CY1114600T1 (no)
DK (1) DK1496858T3 (no)
EA (2) EA200600620A1 (no)
ES (1) ES2434834T3 (no)
HK (2) HK1079092A1 (no)
HR (1) HRP20040933B1 (no)
IL (3) IL163677A0 (no)
ME (1) MEP47108A (no)
MX (1) MXPA04009764A (no)
MY (1) MY153151A (no)
NO (1) NO20044096L (no)
NZ (1) NZ536219A (no)
PE (1) PE20030971A1 (no)
PL (1) PL207750B1 (no)
PT (1) PT1496858E (no)
RS (1) RS52624B (no)
SI (1) SI1496858T1 (no)
TW (1) TWI312688B (no)
UA (1) UA80123C2 (no)
UY (1) UY27751A1 (no)
WO (1) WO2003084502A1 (no)
ZA (1) ZA200406750B (no)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1210017C (zh) 2000-10-12 2005-07-13 贝林格尔英格海姆法玛两合公司 含噻托品鎓的新颖可吸入粉末
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10255387A1 (de) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Tiotropium-haltige Pulverformulierung für die Inhalation
GB0315509D0 (en) 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
PT1682541E (pt) 2003-11-03 2010-04-14 Boehringer Ingelheim Int Processo para a preparação de sais de tiotrópio
DE10352277A1 (de) * 2003-11-08 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverinhalator
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
WO2005053647A1 (en) * 2003-12-03 2005-06-16 Microdrug Ag Medical product containing tiotropium
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
EP1691783B1 (en) * 2003-12-03 2009-11-25 Boehringer Ingelheim International GmbH Pre-metered dry powder inhaler for moisture-sensitive medicaments
DE102004024451A1 (de) 2004-05-14 2005-12-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
JP5078014B2 (ja) 2004-08-20 2012-11-21 マンカインド コーポレイション ジケトピペラジン合成の触媒反応
HUE025151T2 (en) 2004-08-23 2016-01-28 Mannkind Corp Diceto-piperazine salts for drug delivery
WO2006065722A2 (en) * 2004-12-16 2006-06-22 Advanced Inhalation Research, Inc. Compositions and methods for pulmonary conditions
US7694676B2 (en) * 2005-04-22 2010-04-13 Boehringer Ingelheim Gmbh Dry powder inhaler
MX2008001976A (es) 2005-08-15 2008-03-25 Boehringer Ingelheim Int Procedimiento para la preparacion de betamimeticos.
EP1928423B1 (en) 2005-09-14 2015-12-09 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
EP1986679B1 (en) 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
EP2676694B1 (en) 2007-06-15 2017-04-26 Boehringer Ingelheim International GmbH Inhaler
EP2082762A1 (en) * 2008-01-24 2009-07-29 Boehringer Ingelheim International Gmbh Inhaler
KR101558026B1 (ko) * 2008-06-13 2015-10-06 맨카인드 코포레이션 건조 분말 흡입기 및 약물 투여 시스템
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
CA2728523C (en) 2008-06-20 2020-03-10 Mannkind Corporation An interactive apparatus and method for real-time profiling of inhalation efforts
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US8538707B2 (en) * 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
TR201008226A2 (tr) * 2010-10-07 2012-04-24 Bi̇lgi̇ç Mahmut Kapsül içeren bir inhalasyon cihazı.
KR101940832B1 (ko) 2011-04-01 2019-01-21 맨카인드 코포레이션 의약 카트리지용 블리스터 패키지
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
EP2776053A1 (en) 2011-10-24 2014-09-17 MannKind Corporation Methods and compositions for treating pain
CA2878457C (en) 2012-07-12 2021-01-19 Mannkind Corporation Dry powder drug delivery systems and methods
KR101466616B1 (ko) * 2012-10-11 2014-11-28 한미약품 주식회사 건조분말 흡입장치
BR122019026637B1 (pt) 2013-07-18 2023-09-26 Mannkind Corporation Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
GB201408387D0 (en) * 2014-05-12 2014-06-25 Teva Pharmaceuticals Europ B V Treatment of respiratory disorders
RS61567B1 (sr) 2015-12-18 2021-04-29 Jt Int Sa Personalni isparivač
CA173518S (en) 2016-02-08 2017-09-01 Nicoventures Holdings Ltd Cartridge for an electronic cigarette
GB201605100D0 (en) 2016-03-24 2016-05-11 Nicoventures Holdings Ltd Vapour provision system
GB2550540B (en) * 2016-03-24 2021-09-29 Nicoventures Trading Ltd Vapour provision device
GB201605101D0 (en) 2016-03-24 2016-05-11 Nicoventures Holdings Ltd Electronic vapour provision system
GB201605102D0 (en) 2016-03-24 2016-05-11 Nicoventures Holdings Ltd Mechanical connector for electronic vapour provision system
GB201605105D0 (en) 2016-03-24 2016-05-11 Nicoventures Holdings Ltd Vapour provision apparatus
US11524823B2 (en) 2016-07-22 2022-12-13 Nicoventures Trading Limited Case for a vapor provision device
CN109821118A (zh) 2017-11-23 2019-05-31 正大天晴药业集团股份有限公司 新型肺部药物输送系统
CN111542308B (zh) * 2017-12-13 2024-04-02 埃姆弗西斯进出口及分销有限公司 干粉吸入器
KR102420393B1 (ko) 2020-05-28 2022-07-13 제이디코스파마 주식회사 약제 기화 흡입기
KR102494694B1 (ko) 2020-11-10 2023-02-01 권오석 약제 기화 흡입기
CN113926031B (zh) * 2021-11-16 2023-08-15 南京茂升德科技有限公司 一种哮喘病人上药用噻托溴铵粉上药器

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1492A (en) * 1981-07-08 1990-02-16 Draco Ab Powder inhalator
DE3336486A1 (de) * 1982-10-08 1984-04-26 Glaxo Group Ltd., London Medikamenten-eingabegeraet
ZA837318B (en) * 1982-10-08 1985-06-26 Glaxo Group Ltd Device for administering medicaments to patients
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
DE4211475A1 (de) * 1991-12-14 1993-06-17 Asta Medica Ag Pulverinhalator
AU119600S (en) 1993-01-21 1994-03-07 Boehringer Ingelheim Kg Inhaler device
DE4318455A1 (de) * 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
JPH0889576A (ja) * 1994-09-27 1996-04-09 Unisia Jecs Corp 吸入式投薬器
JP3320261B2 (ja) * 1995-06-01 2002-09-03 株式会社ユニシアジェックス 吸入式投薬器
JPH09140796A (ja) * 1995-11-24 1997-06-03 Unisia Jecs Corp 投薬器
JPH09140794A (ja) * 1995-11-27 1997-06-03 Unisia Jecs Corp 投薬器
DK0995457T3 (da) * 1995-12-07 2004-08-16 Jago Res Ag Mundstykke til inhalator til flere dosisvise afgivelser af farmakologisk törpulver
JPH09206378A (ja) * 1996-02-06 1997-08-12 Unisia Jecs Corp 吸入式投薬器
JPH09206380A (ja) * 1996-02-06 1997-08-12 Unisia Jecs Corp 吸入式投薬器
JPH09206381A (ja) * 1996-02-06 1997-08-12 Unisia Jecs Corp 吸入式投薬器
JPH09206379A (ja) * 1996-02-06 1997-08-12 Unisia Jecs Corp 吸入式投薬器
KR100620338B1 (ko) * 1998-03-16 2006-09-13 넥타르 테라퓨틱스 에어로졸형 활성 제제 전달 방법
GB9807558D0 (en) * 1998-04-09 1998-06-10 Bason Neil P An indicator device
JPH11299891A (ja) * 1998-04-21 1999-11-02 Unisia Jecs Corp 吸入式投薬器
PT1283036E (pt) * 1998-11-13 2008-03-06 Jagotec Ag Inalador de pó seco de dose múltipla com um reservatório de pó
GB9902689D0 (en) 1999-02-08 1999-03-31 Novartis Ag Organic compounds
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US6262260B1 (en) * 2000-03-23 2001-07-17 Abbott Laboratories Process for the preparation of midazolam

Also Published As

Publication number Publication date
CA2481876A1 (en) 2003-10-16
JP2005525393A (ja) 2005-08-25
CN101574552B (zh) 2011-12-07
HK1136514A1 (en) 2010-07-02
AU2003226775A1 (en) 2003-10-20
ME00307B (me) 2011-02-10
PE20030971A1 (es) 2003-12-31
MY153151A (en) 2015-01-29
HK1079092A1 (en) 2006-03-31
IL209401A0 (en) 2011-01-31
TWI312688B (en) 2009-08-01
ZA200406750B (en) 2006-05-31
KR101017850B1 (ko) 2011-03-04
DK1496858T3 (da) 2013-11-18
IL163677A0 (en) 2005-12-18
KR20040108704A (ko) 2004-12-24
BR0309117A (pt) 2005-02-01
HRP20040933B1 (hr) 2014-05-23
PT1496858E (pt) 2013-11-20
HRP20040933A2 (en) 2005-02-28
MXPA04009764A (es) 2004-12-13
EP1496858A1 (en) 2005-01-19
CY1114600T1 (el) 2016-10-05
RS52624B (en) 2013-06-28
IL163677A (en) 2012-06-28
EA200600620A1 (ru) 2006-08-25
CN101574552A (zh) 2009-11-11
PL371855A1 (en) 2005-06-27
CN100522135C (zh) 2009-08-05
ES2434834T3 (es) 2013-12-17
EA007302B1 (ru) 2006-08-25
MEP47108A (en) 2011-02-10
AU2009200716A1 (en) 2009-03-19
CN1646095A (zh) 2005-07-27
RS88004A (en) 2006-12-15
EP1496858B1 (en) 2013-08-14
AU2009200716B2 (en) 2011-06-16
NZ536219A (en) 2006-07-28
UY27751A1 (es) 2003-11-28
UA80123C2 (en) 2007-08-27
TW200306863A (en) 2003-12-01
CA2481876C (en) 2011-01-18
EA200401304A1 (ru) 2005-06-30
PL207750B1 (pl) 2011-01-31
AR039276A1 (es) 2005-02-16
SI1496858T1 (sl) 2013-12-31
WO2003084502A1 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
NO20044096L (no) Inhalsjonsett inneholdende inhalerbart pulver av tiotropium
EG24139A (en) New inhalable powder containing tiotropium
EG24478A (en) New inhalable powder containing tiotropium
DE60239639D1 (de) Pulverinhalator
IL179489A0 (en) Securing dose quality of inhalable drug
PL1824566T3 (pl) Kompozycje doustne zawierające ekstrakt z rozmarynu i związane sposoby
IL183308A (en) Cyclopropyl compounds for leucinamide and their use in the preparation of a drug
HK1116800A1 (en) Arylvinylazacycloalkane compounds and methods of preparation and use thereof
ZA200609141B (en) Compositions for Inhalation therapy and methods of use
EP1625111A4 (en) THYRONAMINE DERIVATIVES AND ANALOGUES AND METHODS OF USE THEREOF
IS7501A (is) thurrdufts innöndunar samsetning
ZA200705093B (en) Oral compositions containing extracts of rosmarinus and related methods
PT1567135E (pt) Formulação em pó para inalação contendo tiotrópio
ZA200600561B (en) Combined doses of tiotropium and fluticasone
HK1094153A1 (en) Nasal pharmaceutical composition of piribedil
NO20043865L (no) Pulverinhalat inneholdende CGRP-antagonist BIBN4096 og fremgangsmate for fremstilling derav
DK1675637T3 (da) Inhalator
TW556917U (en) Structure of dual-purpose rhythm clock
TW583928U (en) Structure of caster set for suitcase
PL379270A1 (pl) Sposób otrzymywania powleczonego proszku
GB0422344D0 (en) Miniature asthma inhaler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application